The Palantir controversy escalated in 2019. Activists and human rights organizations criticized the company's contracts with ...
Dan Ives, a Wedbush analyst, has reaffirmed his $75 price target for Palantir, citing strong growth potential driven by its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback